SYNLOGIC, INC. Net Income (Loss), Per Outstanding Limited Partnership and General Partnership Unit, Basic and Diluted, Net of Tax
SYNLOGIC, INC. (SYBX) reported Net Income (Loss), Per Outstanding Limited Partnership and General Partnership Unit, Basic and Diluted, Net of Tax of -$4.49 per share for the 3-month period ending 2017-03-31, per its 10-K filed 2019-03-12.
Discontinued › Income Statement › Other Income
us-gaap:NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted · last filed 2019-03-12
- SYNLOGIC, INC. net income (loss), per outstanding limited partnership and general partnership unit, basic and diluted, net of tax for the quarter ending 2017-03-31 was -$4.49.
- SYNLOGIC, INC. net income (loss), per outstanding limited partnership and general partnership unit, basic and diluted, net of tax for the quarter ending 2016-12-31 was -$4.28.
- SYNLOGIC, INC. net income (loss), per outstanding limited partnership and general partnership unit, basic and diluted, net of tax for the quarter ending 2016-09-30 was -$3.33.
- SYNLOGIC, INC. net income (loss), per outstanding limited partnership and general partnership unit, basic and diluted, net of tax for the quarter ending 2016-06-30 was -$3.17.
- SYNLOGIC, INC. net income (loss), per outstanding limited partnership and general partnership unit, basic and diluted, net of tax for fiscal 2016 was -$13.30.
| Period end | Net Income (Loss), Per Outstanding Limited Partnership and General Partnership Unit, Basic and Diluted, Net of Tax 3 month | Net Income (Loss), Per Outstanding Limited Partnership and General Partnership Unit, Basic and Diluted, Net of Tax 9 month | Net Income (Loss), Per Outstanding Limited Partnership and General Partnership Unit, Basic and Diluted, Net of Tax 12 month |
|---|---|---|---|
| 2017-03-31 | -$4.49 10-K · filed 2019-03-12 | ||
| 2016-12-31 | -$4.28 10-K · filed 2018-03-20 | -$13.30 10-K · filed 2018-03-20 | |
| 2016-09-30 | -$3.33 10-K · filed 2018-03-20 | -$9.17 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$3.17 10-K · filed 2018-03-20 | ||
| 2016-03-31 | -$2.52 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |